Suchen
Crescent Biopharma Ord Shs
CBIOZur Watchlist hinzufügen
14.240USD
+0.050+0.35%
Handelsschluss 09-24 16:00（ET）
507.94MMarktkapitalisierung
VerlustKGV TTM
Über Unternehmen
Crescent Biopharma Ord Shs Profil
Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -
Führungskräfte von Crescent Biopharma Ord Shs
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Dr. Ellie Eunkyung Im
Dr. Ellie Eunkyung Im
Chief Medical Officer
Chief Medical Officer
112.00
-1088.39%
Ms. Alexandra (Alex) Balcom, CPA
Ms. Alexandra (Alex) Balcom, CPA
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Dr. Jonathan Violin, Ph.D.
Dr. Jonathan Violin, Ph.D.
Director
Director
69.52K
--
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Mr. Jonathan McNeill, M.D.
Mr. Jonathan McNeill, M.D.
President, Chief Operating Officer
President, Chief Operating Officer
10.03K
-45.59%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Crescent Biopharma Ord Shs?
Die fünf größten Anteilseigner von Crescent Biopharma Ord Shs sind: Dr. Jonathan Violin, Ph.D.